GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...

Artificial intelligence (AI) can help improve treatment of epilepsy by connecting the dots in complex cases, a new study says ...

Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a ...

Researchers adjusted for confounders like age, hypertension, cardiovascular disease, and other comorbidities. The refined results indicated GLP-1 users had a 16% lower risk of developing epilepsy ...

People with depression have a more than doubled risk of developing epilepsy, and the mental illness also makes epilepsy more ...

Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a ...

Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure ...

"These findings are a reminder that people with epilepsy are searching for answers in online spaces every day," said Douglas ...

Taking GLP-1 medications like Ozempic is linked to a smaller risk of developing epilepsy than taking DPP-4 inhibitors. | Drug ...